Clinical Trial Update: DLBS1449 in Diabetic Patients With Low HDL [Phase 2, Phase 3]

View source ↗

Summary

DLBS1449's Phase 2/3 trial in diabetic patients with low HDL-cholesterol has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• DLBS1449

Snippet

Sponsor: Dexa Medica Group | Conditions: Diabetic Patients, Low HDL-cholesterol (< 35 mg/dL) | Phase 2, Phase 3 | Status: WITHDRAWN